Respiratory distress syndrome (RDS) among preterm infants is typically due to a quantitative deficiency of pulmonary surfactant. Aside from the degree of prematurity, diverse environmental and genetic factors can affect the development of RDS. The variance of the risk of RDS in various races/ethnicities or monozygotic/dizygotic twins has suggested genetic influences on this disorder. So far, several specific mutations in genes encoding surfactant-associated molecules have confirmed this. Specific genetic variants contributing to the regulation of pulmonary development, its structure and function, or the inflammatory response could be candidate risk factors for the development of RDS. This review summarizes the background that suggests the genetic predisposition of RDS, the identified mutations, and candidate genetic polymorphisms of pulmonary surfactant proteins associated with RDS.
Introduction
Respiratory distress syndrome (RDS) is primarily due to the absence or transient defi ciency of pulmonary surfactant (PS) 1) . RDS is a major acute postnatal pulmonary disease that especially affects the preterm newborns, and is caused by an insufficiency of PS metabolism. The disorder can progress to respiratory failure. Although the incidence of RDS is inversely related to gestational age, prematurity alone does not determine the risk of developing the disorder 2) . Besides surfactant deficiency, diverse risk factors such as gender, ethnicity, and maternal diseases, which have interactions with one another, influence the development and the severity of RDS 24) . According to empirical observation and epidemiologic studies concerning racial diffe rences and familial tendency, genetic disposition has been suggested for the risk of RDS 5 7) . In spite of antenatal steroid administration, postnatal surfactant therapy, and optimal ventilator care, not all infants of the same gestational period respond equally to treat ments. From the intractable RDS cases, a few mutations, including genes encoding surfactant proteins B (SPB) 8) , SPC 9) , and the adenosine triphosphatebinding cassette transporter A3 (ABCA3) 10) , have been identified. Specific polymorphisms related to surfactant structure and function, pulmonary differentiation, and inflammatory response could be candidate genes for the development of RDS 2, 1113) . The present review summarizes the genetic aspect of RDS as follows. First, the histolo gical and epidemiologic backgrounds that suggest the genetic predisposition for the development of RDS are introduced; these include studies on ethnic differences, and familial and twin studies. Then, the rare but revealed genetic causes of RDS are described, including the identified surfactantassociated mutations. Lastly, recent studies associating genetic polymorphisms for SP with RDS are shown.
Historical studies that suggest a genetic predisposition to RDS 1. Ethnic/racial differences A higher rate of neonatal death and RDS has been reported for white newborn infants compared with black newborns, in spite of the relatively lower birth weights of the black infants 5) . The study of the US national mortality statistics for RDS in 1968−1973 showed a higher mortality rate in male infants than in female infants, and a lower incidence of fatal RDS in black preterm in fants 3) . On the other hand, there was a report that showed no racial differences in fetal lung maturation between the blacks and whites in the US; the influence of environmental factors, such as maternal body weight and smoking, for the development of RDS was suggested 14) . In spite of these few opposing results 14) , regres sion analyses have shown that RDS occurs less frequently and less severely in black preterm infants, whereas white ethnicity is an independent risk factor of RDS in preterm and term infants 1517) . To date, the underlying mechanisms related to the racial dif ference in the occurrence of RDS have not been definitively re vealed. Olowe and Akinkugbe 18) suggested the earlier pulmonary maturation in Africans as being one of the mechanisms for the racial difference, based on the result of a higher amniotic fluid lecithin/sphingomyelin (L/S) ratio in African babies than in North American babies. Antenatal steroid treatment proved to be effective in nonCaucasians, whereas Caucasians showed little benefit from this intervention 19) . Richardson and Torday 20) stratified the data by L/S ratio to adjust for possible differences in maturational timing between races, and showed lower rates of RDS in the black infants at every level of the L/S ratio. They suggested an alterna tive hypothesis of qualitative differences in the surfactants be tween races, including differences of phospholipids and sur factant proteins, or anatomic differences in the alveolar size and structure. Genetic differences such as allelic variation may contri bute to the protein structure and function 2, 12, 21) .
Family studies
The increased risk of developing RDS with a history of pre viously affected infants has been suggested an important genetic or other familial tendency in its origin 6, 7) . There should be other considerations for the results analysis of the family studies; that is, the possibility of including populations with a genetic predis position to preterm birth, or the confounding environmental effects, as well as genetic influences 2, 6) . Although most of the identified mutations of SPB and ABCA3 are family specific 22, 23) , and dif ferences of SPs or maternal hormonal factor were suggested 6) , the integrative precise mechanism to explain these results is not clear.
Twin studies
Genetic predisposition in the susceptibility to RDS has been suggested by twin studies. The concordance difference of RDS between monozygotic (MZ) and dizygotic (DZ) twins (viz., the higher frequency of RDS in MZ than in DZ twins) supports the genetic contribution to RDS 13, 24) . On the other hand, there was a study showing no significant concordance difference between MZ and DZ twins 25) . Several reports pointed out that concordance twin studies need to consider the differences in the mean gesta tional age, birth weight, and gender between MZ and DZ twins, as well as birth order and intrauterine environmental factors 2, 13, 25) .
Identified mutations of surfactant metabolism
SPB and SPC contribute to the surface tensionlowering ac tivity of the PS. SPB and SPC are encoded by a single gene, located on chromosomes 2 and 8, respectively 2628) . ABCA3, which is a transporter of phospholipid into lamellar bodies (LBs), the storage organelles for the surfactant complex, is critical for the proper formation of LBs and for surfactant function. Mutations in the genes encoding SPB (SFTPB), SPC (SFTPC), and ABCA3 (ABCA3) disrupt surfactant function and cause respiratory distress in the newborn 11, 23, 29) . Table 1 shows repre sentative mutations of SFTPB, SFTPC, and ABCA3.
Hereditary SP-B deficiency
SPB deficiency was first described in two siblings with severe lung disease in the newborn period 8) . Infants with hereditary SPB deficiency, who are typically fullterm, present severe re spiratory failure shortly after birth, which is similar to RDS of preterm infants 30) . The most common mutation, found in 60%−70% of the cases of SPB deficiency 31) , is a 1 basepair (C) deletion and 3 basepair (GAA) insertion, which is a net 2 basepair insertion at codon 121 in exon 4 of SFTPB (termed 121ins2) 32) . It causes a frame shift and premature termination signal of translation, which results in absence of mature SPB production. Infants ho mozygous for this autosomal recessive lossoffunction mutation are refractory to surfactant replacement therapy, and the cases are mostly fatal without lung transplantation 33) . The frequencies of 121ins2 are rare: 0.4% of a cohort in Missouri, 0.1% in Norway, and 0% in Korea and South Africa, in a populationbased study 34) . Besides the 121ins2 mutation, more than 30 lossof function mutations in SFTPB have been identified to date 11, 22, 23, 3537) . Other lossoffunction mutations appear to be family specific and sometimes associated with the partial or transient deficiency of SPB that results in a more gradually progressive and prolonged survival 38, 39) .
Mutations in SFTPC
The SFTPC gene encodes SPC, a hydrophobic protein like SPB, which functions to lower the surface tension of the PS 40) . The surfactant protein C precursor (proSPC) is an essential endoplasmic reticulum (ER) membrane protein with an αhelical transmembrane domain. Various mutations in the ERluminal Cterminal domain of proSPC have been reported 41) . Mutations in SFTPC are thought to result in the production of misfolded proSPC molecules that accumulate within the alveolar type II cells and cause cellular injury. Contrary to SPB, mutations in SFTPC penetrate variably, and its expression ranges from severe RDS of the newborn to chronic interstitial lung disease of the adult or even asymptomatic conditions 9, 4244) . Presentation in full term infants in the newborn period is associated with signs and symptoms typical of RDS, and may be fatal in the neonatal period 45) . Over half of the mutations are thought to arise spontaneously and result in sporadic cases 23) . About 35 dominantly expressed muta tions in SFTPC have been identified, where threonine substitution for isoleucine in codon 73 (I73T) is the most com mon 43) .
Mutations in ABCA3
Several mutations of ABCA3 were first identified in 16 of 21 patients with severe neonatal surfactant deficiency 10) . Markedly abnormal LBs were observed by ultrastructural examination of lung tissue from four patients with different ABCA3 mutations. The clinical manifestation and course of ABCA3 mutations are variable: mutations in this gene can result in fatal surfactant de ficiency in term newborn infants 29) , which have similar clinical and radiologic findings to SPB deficiencies, and chronic inter stitial lung disease in older children 46, 47) . More than 70 mutations have been reported, most of which are family specific 23) . The overall frequency of mutations and disease is unknown. 48, 49) , CCAAT enhancer binding proteinα (C/EBPα) 50) , and forkhead box A2 (Foxa2) 51) , have been identified that influence lung formation and surfac tant production as well as homeostasis in late gestation. TTF1, C/EBPα, and Foxa2 interact reciprocally to regulate transcrip tional targets of surfactant synthesis and peripheral lung matura tion 50) . TTF1, encoded by NKX21, is expressed in the thyroid gland, brain, and lung 48) . In the lung, it is an early marker of lung diffe rentiation and an essential regulator for the expression of SPA, SPB, SPC, and ABCA3 49) . Mutations in NKX21 result in RDS and respiratory failure in newborn infants and in interstitial lung disease in older children 36, 49, 52) . C/EBPα, a member of a family of basic leucine zipper trans cription factors, plays an important role in the synthesis and me tabolism of surfactant lipids and proteins. Deletion of the CEBPA gene causes the inhibition of lung epithelial cell proliferation and differentiation 50) . Deletion of FOXA2 inhibits branching morphogenesis and epi thelial cell differentiation of the lung 51) . Foxa2 modulates gene expression by interacting with other transcription factors. An animal study showed that the mammalian sterile 20like kinase 1 and 2 (Mst1/2) regulated Foxa2, and might be crucial factors in surfactant homeostasis 53) .
Candidate genetic polymorphisms of SPs

SP-A
Among the three forms of PS 54) (viz., intracellular and extra cellular LBs, extracellular tubular myelin [TM] , and surface mo nolayer), TM was absent in the lung of newborns who had died of RDS 55) . Moreover, the expression of SPA was very low 56) . The levels of SPA in tracheal aspirates, cord blood, and serum of newborn infants with RDS were lower than in infants without RDS 5760) . Owing to these significant findings and the important roles of SPA in the pulmonary host defense mechanism and the formation of TM 6163) , the genes expressing SPA have been thought to be strong candidates for susceptibility to RDS.
Two functional genes encoding SPA (SFTPA1 and SFTPA2) are located on chromosome 10q22q23 64) . Various single nucleo tide polymorphisms (SNPs) have been discovered in coding re gions and untranslated regions of SFTPA1 and SFTPA2 6567) , and many association studies with RDS have been reported 6873) . Lee et al. 74) and Kim et al. 75) have presented the distribution and frequency of SPA alleles in Korean newborns. The SPA1 6A . However, these association patterns were significantly diffe rent in a study of Korean preterm infants 71) . The SPA2 1A 0 variant and 1A 0 /1A 0 genotype were associated with protection from RDS, whereas SPA1 6A 2 was not. The contrasting association of RDS with specific SPA variants among different ethnic groups suggests that RDS is a multifactorial disease. In certain studies, associations between specific variants and RDS risk were confirmed under specific conditions or subgroups, such as infants born of twins or specific gestations, having the specific SPB genotype or specific haplotypes of SPA and SPD 69, 72, 73) . Although various associa tion studies of SPA genetic polymorphisms and RDS have been reported, the precise mechanism of the causeandeffect relationship between specific polymorphisms and RDS has not been revealed up to now 12) . Table 2 shows representative genetic polymorphisms of SPs associated with RDS.
SP-B
SPB plays essential roles in forming LBs and maintaining the surface monolayer 76) . SFTPB has been thought to be an important candidate gene for RDS. Hereditary SPB deficiency caused by mutations of SFTPB results in lethal neonatal respiratory disease. The reduction of SPB concentration to <25% of normal levels caused respiratory failure in adult mice 77) . SPB and SPC levels of tracheal aspirate were correlated with surfactant function in premature infants 78) . The SFTPB gene on chromosome 2p12p11.2 is approximately 9.7 kb long, with 11 exons and 10 introns, in cluding a large untranslated region 26) , and is polymorphic 79, 80) . Hamvas et al. 80) reported 86 SFTPB polymorphic sites (9.8/1,000 base pairs of SFTPB reference sequence), including 81 SNPs and 5 small insertion/deletions. Several studies showed specific SNPs or length variation (insertion/deletion polymorphic changes) in intron 4 of SFTPB to be associated with RDS development 25, 79, 81) .
SP-C
SPC is expressed as a proSPC that matures to SPC, containing only 35 amino acids. SFTPC is located on the short arm of chromo some 8 (8p23.1) 27) . Mutations of SFTPB can disturb the proSPC processing 28) . SPC is thought to be a hydrophobic protein critical to lowering surface tension by enhancing the adsorption and spreading of surfactant phospholipids to the pulmonary surface monolayer; however, the exact functional roles of SPC are currently not completely understood. Moreover, studies concerning the distri bution of allelic variation in SFTPC and the associations with human disease are very rare. Lahti et al. 82) showed that SPC poly morphisms were associated with RDS risk among infants born at <28 weeks of gestation.
SP-D
SPD is an important component of the innate pulmonary im mune system and, like SPA, plays a role in PS homeostasis 61, 62) . The SFTPD gene, encoding for SPD, is assigned to chromosome 10q22q23 near SFTPA2 64) . Specific polymorphisms of SFTPD Korean J Pediatr 2014;57(4):157-163 influence the structure, function, and serum concentration of SP D 21, 83) . Associations of protective haplotypes of SPA/SPD with RDS development 73) and specific genotypes of SPD with the severity of RDS 84) have been reported.
Conclusions
Because RDS is thought to be a multifactorial and/or multige netic disease, it is necessary to be wellinformed of the genetic contributors for RDS before designing any studies to search for new factors associated with the disorder.
To date, the frequency of inherited mutations that result in defective surfactant metabolism has not been revealed in the Korean population. Although it seems to be rare, the clinical outcomes of such mutations are mostly fatal. Therefore, we need to investigate the possibility of these mutations and to try to diagnose for them using genetic sequencing in neonatal cases of RDS presenting with an unusual course of severe respiratory failure, especially those with a familial history.
Even though the direct association of genetic polymorphisms with the development of RDS has not been confirmed to date, there have been many meaningful association studies. Large scaled association studies are needed, considering the low penetrance of common genetic variants. The results of association studies can provide basic information for highthroughput genomic and proteomic researches and help to target specific therapies in the future. .
